These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 24798244

  • 1. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
    Ruprecht K, Wunderlich B, Gieß R, Meyer P, Loebel M, Lenz K, Hofmann J, Rosche B, Wengert O, Paul F, Reimer U, Scheibenbogen C.
    J Neuroimmunol; 2014 Jul 15; 272(1-2):56-61. PubMed ID: 24798244
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
    Salzer J, Nyström M, Hallmans G, Stenlund H, Wadell G, Sundström P.
    Mult Scler; 2013 Oct 15; 19(12):1587-91. PubMed ID: 23549431
    [Abstract] [Full Text] [Related]

  • 3. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L, Giess RM, Rasche L, Pfuhl C, Wakonig K, Behrens JR, Scheibenbogen C, Bellmann-Strobl J, Paul F, Reimer U, Ruprecht K.
    J Neuroimmunol; 2016 Aug 15; 297():56-62. PubMed ID: 27397076
    [Abstract] [Full Text] [Related]

  • 4. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1).
    Rumpold H, Rhodes GH, Bloch PL, Carson DA, Vaughan JH.
    J Immunol; 1987 Jan 15; 138(2):593-9. PubMed ID: 2432130
    [Abstract] [Full Text] [Related]

  • 5. Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
    Cortese M, Leng Y, Bjornevik K, Mitchell M, Healy BC, Mina MJ, Mancuso JD, Niebuhr DW, Munger KL, Elledge SJ, Ascherio A.
    JAMA Neurol; 2024 May 01; 81(5):515-524. PubMed ID: 38497939
    [Abstract] [Full Text] [Related]

  • 6. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G.
    Neurology; 2009 Jul 07; 73(1):32-8. PubMed ID: 19458321
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins.
    Mechelli R, Anderson J, Vittori D, Coarelli G, Annibali V, Cannoni S, Aloisi F, Salvetti M, James JA, Ristori G.
    Mult Scler; 2011 Nov 07; 17(11):1290-4. PubMed ID: 21757535
    [Abstract] [Full Text] [Related]

  • 8. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
    Jog NR, McClain MT, Heinlen LD, Gross T, Towner R, Guthridge JM, Axtell RC, Pardo G, Harley JB, James JA.
    J Autoimmun; 2020 Jan 07; 106():102332. PubMed ID: 31515129
    [Abstract] [Full Text] [Related]

  • 9. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K, Tschochner M, James I, Choo L, Dunn DS, Pedrini M, Kermode A, Carroll W, Nolan D.
    Mult Scler; 2014 Mar 07; 20(3):286-94. PubMed ID: 23886832
    [Abstract] [Full Text] [Related]

  • 10. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Huang J, Tengvall K, Lima IB, Hedström AK, Butt J, Brenner N, Gyllenberg A, Stridh P, Khademi M, Ernberg I, Al Nimer F, Manouchehrinia A, Hillert J, Alfredsson L, Andersen O, Sundström P, Waterboer T, Olsson T, Kockum I.
    Brain; 2024 Oct 03; 147(10):3573-3582. PubMed ID: 38630618
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
    DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A.
    Arch Neurol; 2006 Jun 03; 63(6):839-44. PubMed ID: 16606758
    [Abstract] [Full Text] [Related]

  • 12. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N, van Nierop GP, Verjans GM, Osterhaus AD, Middeldorp JM, Hintzen RQ.
    J Clin Virol; 2010 Sep 03; 49(1):26-31. PubMed ID: 20638898
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ.
    JAMA; 2001 Dec 26; 286(24):3083-8. PubMed ID: 11754673
    [Abstract] [Full Text] [Related]

  • 14. Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1.
    Baboonian C, Halliday D, Venables PJ, Pawlowski T, Millman G, Maini RN.
    Rheumatol Int; 1989 Dec 26; 9(3-5):161-6. PubMed ID: 2481875
    [Abstract] [Full Text] [Related]

  • 15. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    Loebel M, Eckey M, Sotzny F, Hahn E, Bauer S, Grabowski P, Zerweck J, Holenya P, Hanitsch LG, Wittke K, Borchmann P, Rüffer JU, Hiepe F, Ruprecht K, Behrends U, Meindl C, Volk HD, Reimer U, Scheibenbogen C.
    PLoS One; 2017 Dec 26; 12(6):e0179124. PubMed ID: 28604802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway.
    Vaughan JH, Riise T, Rhodes GH, Nguyen MD, Barrett-Connor E, Nyland H.
    J Neuroimmunol; 1996 Sep 26; 69(1-2):95-102. PubMed ID: 8823380
    [Abstract] [Full Text] [Related]

  • 18. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.
    JAMA; 2005 May 25; 293(20):2496-500. PubMed ID: 15914750
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D, van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, van Doorn PA, van der Meché FG, Hintzen RQ.
    J Neurol Neurosurg Psychiatry; 2005 Oct 25; 76(10):1377-81. PubMed ID: 16170080
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E, Koptides D, Gaglia E, Constantinou A, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C.
    Mol Immunol; 2019 Jan 25; 105():270-275. PubMed ID: 30562647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.